Russell Investments Group’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-750
| Closed | -$1.61K | – | 3818 |
|
|
2024
Q3 | $1.61K | Hold |
750
| – | – | ﹤0.01% | 3413 |
|
|
2024
Q2 | $3.87K | Hold |
750
| – | – | ﹤0.01% | 3267 |
|
|
2024
Q1 | $4.01K | Hold |
750
| – | – | ﹤0.01% | 2973 |
|
|
2023
Q4 | $5.84K | Hold |
750
| – | – | ﹤0.01% | 2892 |
|
|
2023
Q3 | $2.96K | Hold |
750
| – | – | ﹤0.01% | 3214 |
|
|
2023
Q2 | $2.36K | Hold |
750
| – | – | ﹤0.01% | 3213 |
|
|
2023
Q1 | $2K | Hold |
750
| – | – | ﹤0.01% | 3007 |
|
|
2022
Q4 | $2.69K | Hold |
750
| – | – | ﹤0.01% | 2879 |
|
|
2022
Q3 | $4K | Hold |
750
| – | – | ﹤0.01% | 2884 |
|
|
2022
Q2 | $7K | Sell |
750
-154
| -17% | -$1.44K | ﹤0.01% | 2854 |
|
|
2022
Q1 | $9K | Sell |
904
-51
| -5% | -$508 | ﹤0.01% | 2714 |
|
|
2021
Q4 | $30K | Sell |
955
-74
| -7% | -$2.33K | ﹤0.01% | 2931 |
|
|
2021
Q3 | $45K | Sell |
1,029
-1,005
| -49% | -$44K | ﹤0.01% | 2952 |
|
|
2021
Q2 | $109K | Sell |
2,034
-2,407
| -54% | -$129K | ﹤0.01% | 3040 |
|
|
2021
Q1 | $331K | Buy |
4,441
+4,231
| +2,015% | +$315K | ﹤0.01% | 2676 |
|
|
2020
Q4 | $22K | Sell |
210
-1,665
| -89% | -$174K | ﹤0.01% | 2977 |
|
|
2020
Q3 | $165K | Buy |
1,875
+979
| +109% | +$86.2K | ﹤0.01% | 2844 |
|
|
2020
Q2 | $95K | Buy |
896
+685
| +325% | +$72.6K | ﹤0.01% | 2894 |
|
|
2020
Q1 | $12K | Buy |
+211
| New | +$12K | ﹤0.01% | 2980 |
|
|
2018
Q1 | – | Sell |
-3,342
| Closed | -$330K | – | 3022 |
|
|
2017
Q4 | $330K | Buy |
3,342
+2,439
| +270% | +$241K | ﹤0.01% | 2558 |
|
|
2017
Q3 | $133K | Buy |
+903
| New | +$133K | ﹤0.01% | 2736 |
|